These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34442004)

  • 1. Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients.
    Bosas P; Zaleskis G; Dabkevičiene D; Dobrovolskiene N; Mlynska A; Tikuišis R; Ulys A; Pašukoniene V; Jarmalaitė S; Jankevičius F
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance.
    Yang CH; Lin YS; Ou YC; Weng WC; Huang LH; Lu CH; Hsu CY; Tung MC
    World J Clin Cases; 2021 Feb; 9(5):1026-1036. PubMed ID: 33644166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of quality of life and late biochemical predictors for localized cancer recurrence following radical prostatectomy.
    Friedersdorff F; Buckendahl L; Alt L; Maxeiner A; Hinz S; Bichmann A; Miller K; Magheli A; Busch J
    World J Urol; 2020 Jun; 38(6):1501-1507. PubMed ID: 31463559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
    Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Implications of Peripheral CD3+CD69+ T-Cell And CD8+CD28+ T-Cell Proportions in Patients Prior to Radical Prostatectomy.
    Zhang Y; Zhang Z; Zhang L; Zhao S; Zhao J; Ye Q; Gao Y; Jiang C; Cui D; Xia S; Han B; Jing Y
    Urol J; 2020 May; 17(3):257-261. PubMed ID: 31630384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower postoperative natural killer cell activity is associated with positive surgical margins after radical prostatectomy.
    Lu YC; Kuo MC; Hong JH; Jaw FS; Huang CY; Cheng JC; Kung HN
    J Formos Med Assoc; 2020 Nov; 119(11):1673-1683. PubMed ID: 32081564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
    Ritch CR; You C; May AT; Herrell SD; Clark PE; Penson DF; Chang SS; Cookson MS; Smith JA; Barocas DA
    Urology; 2014 Jun; 83(6):1309-15. PubMed ID: 24746665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry.
    Ong WL; Evans SM; Spelman T; Kearns PA; Murphy DG; Millar JL
    BJU Int; 2016 Oct; 118(4):563-9. PubMed ID: 26573954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of tumor infiltration immune cells in pancreatic cancer].
    Zhao KL; Liu J; Jiang WN; Hao JH
    Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):464-470. PubMed ID: 29886672
    [No Abstract]   [Full Text] [Related]  

  • 11. First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer Pathology.
    Kang JJ; Reiter RE; Steinberg ML; King CR
    Eur Urol Oncol; 2018 Oct; 1(5):378-385. PubMed ID: 31158076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of greater short-term PSA recurrence with laparoscopic as compared to retropubic radical prostatectomy for Japanese clinically localized prostate carcinomas.
    Akita H; Okamura T; Ando R; Nagata D; Naruyama H; Yamada Y; Naiki T; Yasui T; Tozawa K; Kohri K
    Asian Pac J Cancer Prev; 2011; 12(11):2959-61. PubMed ID: 22393971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of single positive surgical margin features on biochemical recurrence after robotic radical prostatectomy.
    Evren I; Hacıislamoğlu A; Ekşi M; Yavuzsan AH; Baytekin F; Çolakoğlu Y; Canoğlu D; Tugcu V
    Int Braz J Urol; 2019; 45(1):45-53. PubMed ID: 30325603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the Biochemical Recurrence risk between Radical Prostatectomy and Brachytherapy in the treatment of low- and intermediate-risk prostate cancer].
    Martínez PF; Belisle DF; Cristallo C; Tobía I; Damia O; Villamil W; Giudice CR
    Arch Esp Urol; 2015 Oct; 68(8):655-60. PubMed ID: 26437328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Second Primary Cancers Affect the Risk of Biochemical Recurrence in Prostate Cancer Patients Undergoing Radical Prostatectomy? A Propensity Score-Matched Analysis.
    Kang M; Jung JW; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
    Clin Genitourin Cancer; 2016 Aug; 14(4):e363-9. PubMed ID: 27105723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review.
    Ilic D; Evans SM; Allan CA; Jung JH; Murphy D; Frydenberg M
    BJU Int; 2018 Jun; 121(6):845-853. PubMed ID: 29063728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy.
    Kang M; Jeong CW; Ku JH; Kwak C; Kim HH
    PLoS One; 2015; 10(3):e0122438. PubMed ID: 25803284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer.
    Wettstein MS; Saba K; Umbehr MH; Murtola TJ; Fankhauser CD; Adank JP; Hofmann M; Sulser T; Hermanns T; Moch H; Wild P; Poyet C
    Prostate; 2017 Apr; 77(5):549-556. PubMed ID: 28093792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Oncologic Outcome of an Initial Series of Laparoscopic Radical Prostatectomy for Clinically Localized Prostate Cancer After a Median Follow-up of 10 Years.
    Mortezavi A; Sulser T; Robbiani J; Drescher E; Disteldorf D; Eberli D; Poyet C; Baumgartner MK; Seifert HH; Hermanns T
    Clin Genitourin Cancer; 2016 Aug; 14(4):290-7. PubMed ID: 26710661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Propensity score comparison of the various radical surgical techniques for high-risk prostate cancer].
    Busch J; Gonzalgo M; Leva N; Ferrari M; Friedersdorff F; Hinz S; Kempkensteffen C; Miller K; Magheli A
    Aktuelle Urol; 2015 Jan; 46(1):45-51. PubMed ID: 25526221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.